Treatment for Telogen Effluvium
How do you treat Telogen Effluvium hair loss?
Although it is only licensed for the treatment of both male and female pattern hair loss, many patients have experienced pleasing results by using minoxidil to treat their Telogen Effluvium. Generally, results should start to become noticeable after two-to-three months of following a personalised minoxidil-based treatment plan.
Belgravia client Miss Kalia, pictured here, is just one example. She says of her hair loss treatment, ‘It really works. I tried everything in the world to stop my hair fall nothing worked. I was depressed and embarrassed. A friend told me about Belgravia. Now a year on I have amazing results.’
You can see a selection of more of these types of images showing clients before and after starting their treatment, demonstrating the level of regrowth they have experienced, along with the time it took them to achieve their results in Belgravia’s Telogen Effluvium Treatment Success Stories gallery.
If you would like more information on the range of high strength minoxidil formulations offered at Belgravia, please contact our hair loss clinics directly by calling 020 7730 6666, or you can send us a message.
Dealing with the underlying cause
As Telogen Effluvium can be caused by a number of factors, it is important that anyone suffering from this hair loss condition is properly diagnosed so that the underlying cause can be identified and dealt with.
This could be due to any number of factors, from vitamin deficiencies to hormonal hair loss in women caused by contraceptive pills or post-pregnancy, or following a traumatic or particularly stressful incident, such as divorce, death or being a victim of crime.
Although it is a temporary hair loss condition which generally corrects itself within six months, treatment for Telogen Effluvium may help to speed up the rate of regrowth.
If you have had all-over shedding for more than six months, this is most likely to be a case of Chronic Telogen Effluvium, also known as Diffuse Thinning.